Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma-Reference-Cited by-同舟云学术

Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma

Published:2019-01-25 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Jung Jun,Suh Yoon Seok,Kim Tae Heon,Jeon Seong Soo,Lee Hyun Moo,Choi Han Yong,Kim Seonwoo,Lee Kyu-Sung

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-36602-x.pdf

Reference19 articles.

1. Oesterling, J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145, 907–923 (1991).

2. Ryoo, H. S. et al. Efficacy of holmium laser enucleation of the prostate based on patient preoperative characteristics. International neurourology journal 19, 278 (2015).

3. Mohler, J. L. et al. Prostate cancer, version 1.2014. J Natl Compr Canc Netw 11, 1471–1479 (2013).

4. Bott, S. R., Henderson, A., Laing, R. W., Montgomery, B. S. & Langley, S. E. Technical considerations when obtaining and interpreting prostatic biopsies from men with a suspicion of early prostate cancer. BJU Int 96, 686 (2005).

5. Benson, M. C. et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147, 815–816 (1992).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study;Asian Journal of Andrology;2023

2. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?;BMC Cancer;2021-04-28